H-1B Filings
36
Major sponsor. DOL labor condition applications on file.
Takeda Pharmaceuticals USA, Inc. in MA (Manufacturing) is dominated by DOL H-1B labor-condition applications (36 on file) at a $190,000 disclosed median; OSHA and WARN tracks are empty here.
Takeda Pharmaceuticals USA, Inc. (MA): · 36 H-1B LCAs at a $190,000 disclosed median
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Takeda Pharmaceuticals USA, Inc. in MA carries 36 H-1B wage filings on record, a $190,000 median wage across 35 disclosed-wage positions (above the $124,488 national median) and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #1,358 of 51,370 sponsors in this corpus (about the 97th percentile), and disclosed median wage sits at the 86th percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B labor condition applications only, OSHA and WARN tracks are empty on this profile.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
H-1B Filings
36
Major sponsor. DOL labor condition applications on file.
Median H-1B Salary
$190,000
Above national median. Across 35 disclosed positions
Where Takeda Pharmaceuticals USA, Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$190,000 Top 14% higher than 86% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (+0.6% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | Takeda Pharmaceuticals USA, Inc. | DOL OFLC |
| Industry | Manufacturing | NAICS / DOL |
| State | MA | U.S. Federal Records |
| H-1B Filings | 36 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $190,000 | DOL OFLC LCA Disclosure |
| Tracks not on file | employer OSHA injury log, WARN notices | Empty by design, not estimated |
Takeda Pharmaceuticals USA, Inc.'s values above reflect the most recent DOL Labor Condition Applications on file for this employer in MA (Manufacturing). In this corpus, H-1B filing volume ranks #1,358 of 51,370 sponsors in this corpus (about the 97th percentile); disclosed median wage sits at the 86th percentile of 272,125 credible H-1B wage rows; WARN history is cleaner than 14% of 304,376 employers tracked here.
| Job Title | Median |
|---|---|
| Director, External Data Execution & Governance | $250,000 |
| Head of Enterprise Strategy Enablement, Commercial | $235,068 |
| Director, Patient Service Enterprise Strategy | $227,773 |
| USBU DD&T Data Products and Services Lead | $225,570 |
| Director, GPD DDT Medical GI TA | $225,000 |
| Product Lead, Omnichannel & Next Gen Engagements-Digital Pla | $215,000 |
| Head of Platform Delivery | $211,967 |
| DD&T Data Governance Lead | $210,000 |
| Global Insights Lead, Hematology Associate Director | $210,000 |
| Service Governance Lead | $207,517 |
| Global Category Mgr - Cell Therapy CMO Process Dev. | $202,288 |
| Associate Director, Omnichannel Engagement PDT | $196,982 |
| Donor Experience Enablement Lead | $195,124 |
| Forecast & Strategy Lead | $192,355 |
| Product Manager, Development and Medical | $191,490 |
| Strategic Analytics and Capabilities Lead, US Oncology | $190,000 |
| Brand Insights and Analytics Lead, US Oncology | $190,000 |
| Assoc. Dir., Sci. & Competitive Analysis, Glbl Oncology | $190,000 |
| Technology Lead - Quality Systems | $188,977 |
| Product Manager | $188,781 |
| Network Platform Owner – LAN and Automation | $182,000 |
| Global Digital Health Technical Product Owner | $180,250 |
| Senior Manager, Analytics and Insights | $179,725 |
| Senior Security Manager | $175,000 |
| Power Apps Platform Owner | $172,895 |
| Platform Architect | $170,000 |
| DDT Engineer Strategy & Business Excellence | $169,366 |
| Lead Analyst, Product Owner | $165,000 |
| DDT Engineer Strategy & Business Excellence | $162,922 |
| Senior Manager, IBD Analytics | $162,552 |
| Sr. Platform Owner - Wireless Networks | $155,000 |
| Data Engineer– SAP BW (GMSGQ) | $150,000 |
| Quality Control Manager | $146,789 |
| Product Mgr, Data Digital & Tech “ Plasma-Derived Therapies | $145,000 |
| Data Platforms Engineer - GMSGQ | $132,226 |
Takeda Pharmaceuticals USA, Inc.'s most extreme placement is sponsorship scale: 36 H-1B LCAs rank higher than 97% of sponsors in this corpus (#1,358 of 51,370).
Disclosed pay runs high: $190,000 median beats 86% of credible wage rows and sits above the $124,488 national median.
Takeda Pharmaceuticals USA, Inc. sponsors 36 H-1B positions but carries no employer OSHA DART rate here — at this filing volume the gap usually reflects recordkeeping exemptions, not a verified safety judgment.
No WARN Act mass-layoff notices are on file for Takeda Pharmaceuticals USA, Inc. among Manufacturing employers we track.
Where Takeda Pharmaceuticals USA, Inc. sits
Across the 200 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, Takeda Pharmaceuticals USA, Inc. files more petitions than 46% of them and discloses a higher median wage than 95%, the selective, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (36 filings · $190,000 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 41; the brand marker is Takeda Pharmaceuticals USA, Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
Takeda Pharmaceuticals USA, Inc.'s nearest H-1B-filing peers in Manufacturing (home state MA). Each card links to that employer's federal-records profile.
What to check before working with Takeda Pharmaceuticals USA, Inc.
For Takeda Pharmaceuticals USA, Inc., start with sponsorship pay (36 H-1B LCAs, median $190,000) and only then layer any other federal silence.
Takeda Pharmaceuticals USA, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, Takeda Pharmaceuticals USA, Inc.'s disclosed median of $190,000 sits at the 86th percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
Takeda Pharmaceuticals USA, Inc. has 36 H-1B filings on record, ranking #1,358 of 51,370 sponsors in this corpus (about the 97th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.